Advertisement

ADVERTISEMENT

Rebecca Mashaw

Conference coverage
Machine Learning Model May Predict Difficult-to-Treat RA
11/20/2024
Earlier identification of patients at risk of developing difficult-to-treat rheumatoid arthritis would allow treatment to begin sooner and optimize outcomes, researchers say.
Earlier identification of patients at risk of developing difficult-to-treat rheumatoid arthritis would allow treatment to begin sooner and optimize outcomes, researchers say.
Earlier identification of...
11/20/2024
Rheumatology & Arthritis
Josh Baker
Conference coverage
Metabolic Syndrome and Response to RA Therapies
11/20/2024
Metabolic syndrome is associated with lower response rates among patients with rheumatoid arthritis on biologic therapy, according to research presented at ACR Convergence 2024.
Metabolic syndrome is associated with lower response rates among patients with rheumatoid arthritis on biologic therapy, according to research presented at ACR Convergence 2024.
Metabolic syndrome is associated...
11/20/2024
Rheumatology & Arthritis
News
Socioeconomics and Sex Affect Function in axSpA
11/06/2024
New research aimed to determine whether the socioeconomic status and sex of people with axial spondyloarthritis might affect their functional status.
New research aimed to determine whether the socioeconomic status and sex of people with axial spondyloarthritis might affect their functional status.
New research aimed to determine...
11/06/2024
Rheumatology & Arthritis
liver
Conference Coverage
Mixed CCA/HCC Tumors: A Real Thing
10/17/2023
Rare and often refractory, mixed cholangiocarcinoma-hepatocellular tumors present diagnostic and treatment challenges that may require a variety of agents in combination, according to Binbin Zheng-Lin, MD.
Rare and often refractory, mixed cholangiocarcinoma-hepatocellular tumors present diagnostic and treatment challenges that may require a variety of agents in combination, according to Binbin Zheng-Lin, MD.
Rare and often refractory, mixed...
10/17/2023
Gastroenterology
News
NAFLD, NASH, Drive Cirrhosis Rates and Liver Cancer Deaths
07/17/2023
NAFLD-related liver cancer deaths rose faster than other causes, while NASH has become the primary cause of cirrhosis.
NAFLD-related liver cancer deaths rose faster than other causes, while NASH has become the primary cause of cirrhosis.
NAFLD-related liver cancer...
07/17/2023
Gastroenterology
Conference Coverage
Is There a Window of Opportunity in Psoriatic Arthritis?
12/13/2023
Early referral to rheumatologists of patients who present with symptoms of psoriatic arthritis (PsA) is associated with better clinical outcomes.
Early referral to rheumatologists of patients who present with symptoms of psoriatic arthritis (PsA) is associated with better clinical outcomes.
Early referral to...
12/13/2023
Rheumatology & Arthritis
News
Complicated Crohn's Phenotypes Create High Disease Burden
07/19/2023
Patients with stricturing and penetrating Crohn's disease are more likely to receive biologics but still experience more extraintestinal manifestations and surgeries.
Patients with stricturing and penetrating Crohn's disease are more likely to receive biologics but still experience more extraintestinal manifestations and surgeries.
Patients with stricturing and...
07/19/2023
Advances in Inflammatory Bowel Disease Network
PsA hand
News
PRESTO: New Tool Predicts Progression to PsA
10/16/2023
Researchers have created a simple tool to provide risk estimations for development of psoriatic arthritis among patients with psoriasis.
Researchers have created a simple tool to provide risk estimations for development of psoriatic arthritis among patients with psoriasis.
Researchers have created a...
10/16/2023
Rheumatology & Arthritis
FDA Alert
News
FDA Grants Fast Track Designation for Efinopegdutide for NASH
06/21/2023
Merck will present phase 2a findings on its investigational glucagon-like peptide 1/glucagon receptor coagonist at the European Association for the Study of the Liver conference on June 23.
Merck will present phase 2a findings on its investigational glucagon-like peptide 1/glucagon receptor coagonist at the European Association for the Study of the Liver conference on June 23.
Merck will present phase 2a...
06/21/2023
Gastroenterology
Conference Coverage
Positive or Negative? Multimorbidity and Disease Activity in RA
12/27/2023
Investigators examined the association between multimorbidity in rheumatoid arthritis and its association with flares and remission in comparison to seropositivity.
Investigators examined the association between multimorbidity in rheumatoid arthritis and its association with flares and remission in comparison to seropositivity.
Investigators examined the...
12/27/2023
Rheumatology & Arthritis

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

November 23 ⁠–⁠ November 24
December 4 ⁠–⁠ December 5
Great Debates & Updates in Diabetic Foot
December 6 ⁠–⁠ December 7
AIBD logo
December 9 ⁠–⁠ December 11
December 9 ⁠–⁠ December 11
Psych Congress Primary Care Online Series
December 12 ⁠–⁠ December 13
December 14 ⁠–⁠ December 15
February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use